126 related articles for article (PubMed ID: 2777412)
1. Stability of phenotypic and genotypic traits during the establishment of a human neuroblastoma cell line, IGR-N-835.
Bettan-Renaud L; Bayle C; Teyssier JR; Benard J
Int J Cancer; 1989 Sep; 44(3):460-6. PubMed ID: 2777412
[TBL] [Abstract][Full Text] [Related]
2. Phenotypic and genotypic diversity of human neuroblastoma studied in three IGR cell line models derived from bone marrow metastases.
Valent A; Bénard J; Vénuat AM; Silva J; Duverger A; Duarte N; Hartmann O; Spengler BA; Bernheim A
Cancer Genet Cytogenet; 1999 Jul; 112(2):124-9. PubMed ID: 10686938
[TBL] [Abstract][Full Text] [Related]
3. Human neuroblastoma cell lines that express N-myc without gene amplification.
Wada RK; Seeger RC; Brodeur GM; Einhorn PA; Rayner SA; Tomayko MM; Reynolds CP
Cancer; 1993 Dec; 72(11):3346-54. PubMed ID: 8242562
[TBL] [Abstract][Full Text] [Related]
4. N-myc amplification at chromosome band 1p32 in neuroblastoma cells as investigated by in situ hybridization.
Longo L; Christiansen H; Christiansen NM; Cornaglia-Ferraris P; Lampert F
J Cancer Res Clin Oncol; 1988; 114(6):636-40. PubMed ID: 3204111
[TBL] [Abstract][Full Text] [Related]
5. Bi-modal differentiation pattern in a new human neuroblastoma cell line in vitro.
Matsushima H; Bogenmann E
Int J Cancer; 1992 May; 51(2):250-8. PubMed ID: 1568793
[TBL] [Abstract][Full Text] [Related]
6. Coactivation of the MDR1 and MYCN genes in human neuroblastoma cells during the metastatic process in the nude mouse.
Ferrandis E; Da Silva J; Riou G; Bénard I
Cancer Res; 1994 Apr; 54(8):2256-61. PubMed ID: 8174136
[TBL] [Abstract][Full Text] [Related]
7. Establishment and characterization of a human neuroblastoma cell line.
Scarpa S; Dominici C; Grammatico P; Del Porto G; Raschellà G; Castello M; Forni G; Modesti A
Int J Cancer; 1989 Apr; 43(4):645-51. PubMed ID: 2703273
[TBL] [Abstract][Full Text] [Related]
8. Morphological and cytogenetic characterization and N-myc oncogene analysis of a newly established neuroblastoma cell line.
Nojima T; Abe S; Furuta Y; Nagashima K; Alam AF; Takada N; Sasaki F; Hata Y
Acta Pathol Jpn; 1991 Jul; 41(7):507-15. PubMed ID: 1755317
[TBL] [Abstract][Full Text] [Related]
9. [Oncogen N-myc expression and measurement of DNA ploidy in neuroblastoma: a double staining flow cytometric analysis].
Chassevent A; Bénard J
Bull Cancer; 1997 Mar; 84(3):29-34. PubMed ID: 9207866
[TBL] [Abstract][Full Text] [Related]
10. Prolonged N-myc protein half-life in a neuroblastoma cell line lacking N-myc amplification.
Cohn SL; Salwen H; Quasney MW; Ikegaki N; Cowan JM; Herst CV; Kennett RH; Rosen ST; DiGiuseppe JA; Brodeur GM
Oncogene; 1990 Dec; 5(12):1821-7. PubMed ID: 2284101
[TBL] [Abstract][Full Text] [Related]
11. Genetic clinical markers of human neuroblastoma with special reference to N-myc oncogene: amplified or not amplified?--An overview.
Tsuchida Y; Hemmi H; Inoue A; Obana K; Yang HW; Hayashi Y; Kanda N; Shimatake H
Tumour Biol; 1996; 17(2):65-74. PubMed ID: 8658015
[TBL] [Abstract][Full Text] [Related]
12. [Oncogene amplification in human neuroblastomas].
Kanda N; Tsuchida Y; Hayashi Y; Ise T; Takayama J; Utakoji T
Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 2):661-6. PubMed ID: 3963837
[TBL] [Abstract][Full Text] [Related]
13. Stromal cells and human malignant neuroblasts derived from bone marrow metastasis may share common karyotypic abnormalities: the case of the IGR-N-91 cell line.
Valent A; Venuat AM; Danglot G; Da Silva J; Duarte N; Bernheim A; Bénard J
Med Pediatr Oncol; 2001 Jan; 36(1):100-3. PubMed ID: 11464856
[TBL] [Abstract][Full Text] [Related]
14. Diverse responses to retinoid in morphological differentiation, tumorigenesis and N-myc expression in human neuroblastoma sublines.
Hino T; Sugimoto T; Matsumura T; Horii Y; Inazawa J; Sawada T
Int J Cancer; 1989 Aug; 44(2):286-91. PubMed ID: 2547728
[TBL] [Abstract][Full Text] [Related]
15. Growth patterns of human neuroblastoma xenografts and their relationship to treatment outcome.
George BA; Yanik G; Wells RJ; Martin LW; Soukup S; Ballard ET; Gartside PS; Lampkin BC
Cancer; 1993 Dec; 72(11):3331-9. PubMed ID: 8242560
[TBL] [Abstract][Full Text] [Related]
16. Pleiotropic over-expression of multidrug-resistance-related genes is correlated to MYCN and max mRNA accumulation during tumour progression in the IGR-N-91 human neuroblastoma model.
Cappellen D; Bénard J
Int J Cancer; 1997 Feb; 70(4):430-6. PubMed ID: 9033651
[TBL] [Abstract][Full Text] [Related]
17. Retinoic acid treatment of human neuroblastoma cells is associated with decreased N-myc expression.
Amatruda TT; Sidell N; Ranyard J; Koeffler HP
Biochem Biophys Res Commun; 1985 Feb; 126(3):1189-95. PubMed ID: 3977910
[TBL] [Abstract][Full Text] [Related]
18. The expression of multiple proto-oncogenes is differentially regulated during retinoic acid induced maturation of human neuroblastoma cell lines.
Thiele CJ; Deutsch LA; Israel MA
Oncogene; 1988 Sep; 3(3):281-8. PubMed ID: 3060792
[TBL] [Abstract][Full Text] [Related]
19. [Establishment and characterization of human neuroblastoma cell line (HSNB)].
Ono I; Ishiwata I; Nakaguchi T; Ohara K; Tokita N; Soma M; Ishiwata C; Nozawa S; Ishikawa H
Hum Cell; 1989 Dec; 2(4):416-22. PubMed ID: 2486666
[TBL] [Abstract][Full Text] [Related]
20. MYCN enhances P-gp/MDR1 gene expression in the human metastatic neuroblastoma IGR-N-91 model.
Blanc E; Goldschneider D; Ferrandis E; Barrois M; Le Roux G; Leonce S; Douc-Rasy S; Bénard J; Raguénez G
Am J Pathol; 2003 Jul; 163(1):321-31. PubMed ID: 12819037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
